What You Ought to Know:
– Panther Life Sciences, a life sciences firm specializing in skin-based remedies utilizing microarray patches (MAPs), has introduced the appointment of Dr. Matthew Hepburn as Govt Vice President of Analysis and Improvement.
– Dr. Hepburn might be instrumental in driving Panther’s strategic imaginative and prescient to commercialize its patented MAP expertise, with a give attention to delivering the primary business product to market inside the subsequent two years.
– In his new function, Dr. Hepburn will spearhead the development of Panther’s in depth pipeline of MAP-based remedies throughout numerous therapeutic areas. This initiative goals to capitalize on the multi-billion-dollar market potential for shelf-stable, direct-to-consumer remedies for immune-mediated ailments and different vital well being situations.
Dr. Hepburn Bio/Background
Dr. Hepburn brings a wealth of experience in infectious ailments and a confirmed observe report in fast product growth. Notably, he served because the vaccine growth lead for Operation Warp Velocity throughout the first Trump Administration, the place he performed a pivotal function in delivering the primary COVID-19 vaccine pictures in report time. His distinguished profession additionally contains strategic pandemic preparedness and biodefense roles on the White Home, reflecting his deep understanding of crucial healthcare challenges.
A doctor and U.S. Military veteran with 23 years of service, Dr. Hepburn’s distinctive mix of scientific expertise and fast growth experience might be invaluable as Panther scales its MAP platform to deal with situations corresponding to most cancers, allergy symptoms, and infectious ailments on a worldwide scale.
“By making our revolutionary MAP platform widely-accessible, Panther is poised to revolutionize the way in which remedies are delivered, enhancing affected person outcomes and considerably decreasing healthcare value all through,” stated Dr. Hepburn. “I’m impressed by the potential of Panther’s MAP expertise and with our companions, I’m absolutely dedicated to bringing established and novel remedies to market sooner and extra effectively.”